Device/Diagnostics Quarterly Dealmaking Statistics, Q3 2019
A Look At The Financing, M&A And Alliance Activity In July–September 2019
Executive Summary
Device financing increased substantially in Q3, thanks to debt raises led by Insulet. Acquisition dollar volume dropped, though, but Siemens' buy of Corindus for $1.1bn was a stand-out. Diagnostics/research tools financing dropped by 28% from Q2, while acquisition value greatly increased due to Exact Sciences' $2.8bn purchase of Genomic Health.